{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whitlow-staphylococcal-herpetic/prescribing-information/flucloxacillin/","result":{"pageContext":{"chapter":{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin","depth":2,"htmlHeader":"<!-- begin field aa262b0a-08f7-46ca-b7fb-d40c03f4f713 --><h2>Flucloxacillin</h2><!-- end field aa262b0a-08f7-46ca-b7fb-d40c03f4f713 -->","summary":"","htmlStringContent":"<!-- begin item 51c4ec96-4cb2-4a59-bd95-6825fd11d7b1 --><!-- end item 51c4ec96-4cb2-4a59-bd95-6825fd11d7b1 -->","topic":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea","topicId":"f989f159-ab30-4d16-b9df-b534a9fd4192","topicName":"Whitlow (staphylococcal and herpetic)","slug":"whitlow-staphylococcal-herpetic","lastRevised":"Last revised in January 2021","chapters":[{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"895f3b40-8720-5843-8910-fe1b288857a8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7e4ec3c7-b080-5717-b1c3-0003acba46e5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7c70fe97-728d-5bc4-94c2-1996b37ee0f9","slug":"changes","fullItemName":"Changes"},{"id":"4889bd92-0b32-558d-8390-80d27fbcce73","slug":"update","fullItemName":"Update"}]},{"id":"1a79ca57-c8cc-5044-ac68-5d220bab1460","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"684fde23-e839-56ff-8b7f-8e6863b2c42d","slug":"goals","fullItemName":"Goals"},{"id":"97b35971-df6d-5ecb-a631-dfcf580e1fa9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12181a78-1b8d-58b4-884a-8930d15cf654","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"521ae353-eea7-5e2f-bd0e-b292540b72eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87054726-2905-5ac0-b369-92e5fd68a177","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b6dffce-588f-532a-9776-7e3ff32005ee","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2d957194-aa56-5cb7-98aa-cb3d8f988743","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f0191f08-fb2e-5c5b-957c-8a190d5b4539","slug":"definition","fullItemName":"Definition"},{"id":"b8b2a1f1-fbc7-5b8f-a5c4-c0e9409d566f","slug":"causes","fullItemName":"Causes"},{"id":"c7287d38-e377-5d65-9c4f-3201369e0213","slug":"prevalence","fullItemName":"Prevalence"},{"id":"adc749af-b4d0-50c9-9996-b470b8f76613","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d632b72f-6e73-58ee-9d8d-21b6101f6394","slug":"prognosis","fullItemName":"Prognosis"},{"id":"faed0075-1878-5f17-abc9-9316eaa064e7","slug":"complications","fullItemName":"Complications"}]},{"id":"96e4a200-e348-5fab-89e2-f0ba789b7b72","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"910097a7-71be-5c13-949e-0be7c045df35","slug":"diagnosis-of-whitlow","fullItemName":"Diagnosis of whitlow"},{"id":"6f468174-fafe-579c-90f9-500f22e70e17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","fullItemName":"Management","slug":"management","subChapters":[{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow"},{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow"}]},{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ae3b006b-c4df-5e15-aee8-5ac6c019923f","slug":"aciclovir","fullItemName":"Aciclovir"},{"id":"46185de6-35ef-5e34-a1fd-e0d1463c538e","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"2a50e932-9f92-5a94-a8e5-aab1ee400b9d","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin"}]},{"id":"98ea0d83-9b18-58b4-aa73-7a50d72e15ba","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dd77db6-a4e1-5304-8a06-196e7628f612","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0191f79d-0e03-554c-b0bd-4b592d452f4a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3e95c155-472c-52d0-9098-a797cec2ad27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f39c5716-7472-576a-be8f-7d705a0dc4dd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"73c24405-a40a-51ba-ac01-8dd957f7c657","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7005b3b9-63e2-5222-840e-73155dac338e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"18dd81bb-78d7-57f1-9fc9-24aa775b3c9d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"808c96a6-6b65-5899-852b-eb5d606ca24d","slug":"dose","fullItemName":"Dose","depth":3,"htmlHeader":"<!-- begin field c0ab5fa8-7f19-4dd3-b751-47636e25d273 --><h3>What dose of flucloxacillin should I prescribe?</h3><!-- end field c0ab5fa8-7f19-4dd3-b751-47636e25d273 -->","summary":"","htmlStringContent":"<!-- begin item c7f6d26a-b9a6-44dc-a7e7-a5cc51172733 --><!-- begin field 575df683-5304-478c-97e6-e7927e768a6c --><ul><li>Flucloxacillin doses:<ul><li>Adults and children older than 10 years of age — 250 mg to 500 mg, four times a day for 7 days.</li><li>Children 2–10 years of age — 125 mg to 250 mg, four times a day for 7 days.</li><li>Children 1 month to 2 years of age — 62.5 mg to 125 mg, four times a day for 7 days.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF for Children, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">PHE, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>]</p><!-- end field 575df683-5304-478c-97e6-e7927e768a6c --><!-- end item c7f6d26a-b9a6-44dc-a7e7-a5cc51172733 -->","subChapters":[]},{"id":"5307ed35-83cd-5821-91ba-d661240d3a30","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field f78c63b9-de4a-4dd8-b59e-49dcda27881e --><h3>What are the contraindications and cautions for flucloxacillin?</h3><!-- end field f78c63b9-de4a-4dd8-b59e-49dcda27881e -->","summary":"","htmlStringContent":"<!-- begin item e7e6c645-80c8-403c-a80b-657f4e4fe03b --><!-- begin field 7cc14573-36c5-4f7f-bdd2-d3de551fb491 --><ul><li><strong>Do not prescribe flucloxacillin</strong> to people with:<ul><li>A true penicillin allergy — gastrointestinal adverse effects alone (for example nausea, vomiting, or diarrhoea) do not constitute an allergy to penicillin.</li><li>History of flucloxacillin-associated jaundice or hepatic dysfunction.</li></ul></li><li><strong>Prescribe flucloxacillin with caution</strong> to people with: <ul><li>Hepatic dysfunction (not flucloxacillin-related), especially if they are 50 years of age or older, or have a serious underlying medical condition.</li><li>Severe renal impairment — reduce the dose if the person's estimated Glomerular Filtration Rate (eGFR) is less than 10 mL/minute/1.73 m<sup>2</sup>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">ABPI, 2015d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>]</p><!-- end field 7cc14573-36c5-4f7f-bdd2-d3de551fb491 --><!-- end item e7e6c645-80c8-403c-a80b-657f4e4fe03b -->","subChapters":[]},{"id":"5ffd78d0-4c07-5dd7-8386-14208b62191e","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field a34c38ce-e573-4b94-8254-036d5394f411 --><h3>What are the adverse effects of flucloxacillin?</h3><!-- end field a34c38ce-e573-4b94-8254-036d5394f411 -->","summary":"","htmlStringContent":"<!-- begin item 3e1fa9ef-7cb5-4a92-9f41-41b75a4ec47d --><!-- begin field 2a3bf0e0-b1ca-4a08-9621-d9d6a2f905d0 --><ul><li>Diarrhoea is a common adverse effect of flucloxacillin.</li><li>Cholestatic jaundice and hepatitis may occur (very rarely) up to several weeks after treatment with flucloxacillin has been stopped. Risk factors include treatment for more than 2 weeks, and increasing age.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">ABPI, 2015d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>]</p><!-- end field 2a3bf0e0-b1ca-4a08-9621-d9d6a2f905d0 --><!-- end item 3e1fa9ef-7cb5-4a92-9f41-41b75a4ec47d -->","subChapters":[]},{"id":"4cfef2a4-9a27-5841-b003-c103944f992f","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 63695847-20ed-4163-8d92-f0852bbfa479 --><h3>What are the drug interactions with flucloxacillin?</h3><!-- end field 63695847-20ed-4163-8d92-f0852bbfa479 -->","summary":"","htmlStringContent":"<!-- begin item 83125312-6ac4-4713-a4c3-4e73c33a373b --><!-- begin field 16ea0a67-9bce-4c8e-876a-0de409e46078 --><ul><li><strong>Drug interactions with flucloxacillin include:</strong><ul><li>Anticoagulants such as warfarin — consider monitoring the international normalized ratio (INR) and adjust the warfarin dose accordingly.</li><li>Methotrexate — flucloxacillin may reduce clearance of methotrexate and increase the risk of toxicity. Consider monitoring concurrent use. One recommendation is to carry out a twice-weekly platelet and white cell count for 2 weeks initially, and measure methotrexate levels if toxicity is suspected.</li><li>Oral hormonal contraception — additional contraceptive precautions are not required during or after courses of flucloxacillin.<ul><li>However, women should be advised about the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">FSRH, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Preston, 2015</a>]</p><!-- end field 16ea0a67-9bce-4c8e-876a-0de409e46078 --><!-- end item 83125312-6ac4-4713-a4c3-4e73c33a373b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}